ICH-GCP E6(R3) draft version released...

  • 24 May 23

This version focuses on the use of new technologies especially in monitoring, data management and responsibilities.

Read More…

20 May - World Clinical Trials Day

  • 19 May 23

Turkish Clinical Research Association celebrates 20 May - World Clinical Trials Day.
In 1747, Scottish Ship Surgeon James Lind made an attempt to figure out how to treat scurvy. This trial is now recognized as the first clinical trial and is accepted as International Clinical Research Day on May 20th.

Read More…

No more animal tests before human drug trials...

  • 16 Jan 23

After legislation signed by President Joe Biden, U.S. Food and Drug Administration (FDA) will not require animal tests before human drug trials. This is applicable to drugs and biologicals.

Read More…

Happy New Year..

  • 29 Dec 22

Turkish Clinical Research Association wishes a happy and healthy 2022 without COVID-19...

Read More…

European Commission proposes EU MDR deadline delay…

  • 12 Dec 22

The European Union’s Health Commission proposed pushing back the deadline for the new medical device regulation (MDR) law to 2028. The deadline for high-risk products will be 2027. and a 2028 deadline for medium and low-risk devices is proposed.

Read More…

Papers from Nobel laureate are getting retracted…

  • 13 Nov 22

Articles co-authored by Nobel-prizewinning geneticist Gregg Semenza are under concern after the comments on the website PubPeer about the integrity of images in the papers.

Read More…

FDA Issues Final Guidance about Multiple Endpoints in Clinical Trials...

  • 22 Oct 22

As the number of endpoints analyzed in a single trial increases, the likelihood of making false conclusions about a drug’s effects with respect to one or more of those endpoints becomes a concern if there is not appropriate adjustment for multiplicity. The purpose of this guidance is to describe various strategies for grouping and ordering endpoints for analysis and applying some well-recognized statistical methods for managing multiplicity within a study in order to control the chance of making erroneous conclusions about a drug’s effects.

Read More…

Sulfonilamide disaster again?

  • 11 Oct 22

The WHO issued an alert over four cough syrup-based products manufactured by Maiden Pharmaceuticals from India. There are 66 reported children deaths.

Read More…

EMA qualifies first Machine Learning based artificial Intelligence program for clinical trials...

  • 28 Sep 22

This qualification is the first time a regulatory body has formally supported a machine learning-based method for reducing sample size in Phase II or III trials.

Read More…

Draft Guidance from FDA that aims to protect Children who participate in Clinical Trials

  • 25 Sep 22

FDA issued a Draft Guidance that aims to protect Children who participate in Clinical Trials. To read the draft click here...

Read More…